Revolution Medicines (RVMD) Net Margin (2019 - 2023)
Revolution Medicines (RVMD) posted quarterly Net Margin of 21770.49% for Q4 2023, down 2140175.0% year-over-year from N/an in Q4 2022, and down 746.92% quarter-over-quarter from 2570.55% in Q2 2023.
Revolution Medicines (RVMD) Net Margin (2019 - 2023) Analysis & Trends
Revolution Medicines' Net Margin history runs 5 years deep, the most recent figure standing at 21770.49% for Q4 2023.
- In Q4 2023, Net Margin fell 2140175.0% year-over-year to 21770.49%; the TTM figure through Sep 2024 stood at 76423.32% (down 7515705.0% YoY), while the FY2023 annual figure was 3768.28%, down 306533.0% from the prior year.
- Net Margin for Q4 2023 stood at 21770.49%, down from 2570.55% in the prior quarter.
- The five-year high for Net Margin was 97.27% in Q1 2019, with the low at 21770.49% in Q4 2023.
- The 5-year median for Net Margin is 390.86% (2020), against an average of 1952.74%.
- The sharpest annual moves came in 2022 and 2023: Net Margin soared 262334 bps in 2022, then plunged 2140175 bps in 2023.
- Revolution Medicines' Net Margin stood at 155.91% in 2019, then sank by 151 bps to 390.86% in 2020, then tumbled by 42 bps to 556.83% in 2021, then surged by 34 bps to 368.73% in 2022, then plunged by 5804 bps to 21770.49% in 2023.
- Business Quant data shows RVMD's Net Margin at 21770.49% in Q4 2023, 2570.55% in Q2 2023, and 970.89% in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 30.33% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.90% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 30.98% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 12.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -3.12% |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -20,152.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -21,770.49% |
| Jun 30, 2023 | -2,570.55% |
| Mar 31, 2023 | -970.89% |
| Dec 31, 2022 | -368.73% |
| Sep 30, 2022 | -2,185.01% |
| Jun 30, 2022 | -671.59% |
| Mar 31, 2022 | -760.72% |
| Dec 31, 2021 | -556.83% |
| Sep 30, 2021 | -4,808.36% |
| Jun 30, 2021 | -509.30% |
| Mar 31, 2021 | -366.95% |
| Dec 31, 2020 | -390.86% |
| Sep 30, 2020 | -215.00% |
| Jun 30, 2020 | -271.47% |
| Mar 31, 2020 | -188.27% |
| Dec 31, 2019 | -155.91% |
| Sep 30, 2019 | -136.45% |
| Jun 30, 2019 | -107.34% |
| Mar 31, 2019 | -97.27% |